These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33589432)

  • 21. Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents.
    Cao H; Li L; Yang D; Zeng L; Yewei X; Yu B; Liao G; Chen J
    Eur J Med Chem; 2019 Oct; 179():537-546. PubMed ID: 31276898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 23. G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR.
    Yin C; Ke X; Zhang R; Hou J; Dong Z; Wang F; Zhang K; Zhong X; Yang L; Cui H
    FASEB J; 2019 Dec; 33(12):14036-14050. PubMed ID: 31647887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a Highly Potent Lysine Methyltransferases G9a/NSD2 Dual Inhibitor to Treat Solid Tumors.
    Yang C; Li B; Feng Z; Li H; Yang H; Yang Z; Liu L; Shi Q; Wang H; Chen ZZ; Huang X; Wang J; Wang Y
    J Med Chem; 2024 Sep; 67(18):16072-16087. PubMed ID: 39008565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormal overexpression of G9a in melanoma cells promotes cancer progression via upregulation of the Notch1 signaling pathway.
    Dang NN; Jiao J; Meng X; An Y; Han C; Huang S
    Aging (Albany NY); 2020 Feb; 12(3):2393-2407. PubMed ID: 32015216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.
    Hua KT; Wang MY; Chen MW; Wei LH; Chen CK; Ko CH; Jeng YM; Sung PL; Jan YH; Hsiao M; Kuo ML; Yen ML
    Mol Cancer; 2014 Aug; 13():189. PubMed ID: 25115793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells.
    Yuan Y; Tang AJ; Castoreno AB; Kuo SY; Wang Q; Kuballa P; Xavier R; Shamji AF; Schreiber SL; Wagner BK
    Cell Death Dis; 2013 Jun; 4(6):e690. PubMed ID: 23807219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
    Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histone lysine methyltransferase G9a is a novel epigenetic target for the treatment of hepatocellular carcinoma.
    Yokoyama M; Chiba T; Zen Y; Oshima M; Kusakabe Y; Noguchi Y; Yuki K; Koide S; Tara S; Saraya A; Aoyama K; Mimura N; Miyagi S; Inoue M; Wakamatsu T; Saito T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Yokosuka O; Iwama A
    Oncotarget; 2017 Mar; 8(13):21315-21326. PubMed ID: 28423509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
    Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
    Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights for the design of protein lysine methyltransferase G9a inhibitors.
    Charles MRC; Dhayalan A; Hsieh HP; Coumar MS
    Future Med Chem; 2019 May; 11(9):993-1014. PubMed ID: 31141392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological and transcriptional inhibition of the G9a histone methyltransferase suppresses proliferation and modulates redox homeostasis in human microvascular endothelial cells.
    Wojtala M; Macierzyńska-Piotrowska E; Rybaczek D; Pirola L; Balcerczyk A
    Pharmacol Res; 2018 Feb; 128():252-263. PubMed ID: 29113759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of H3K9 methyltransferase G9a repressed cell proliferation and induced autophagy in neuroblastoma cells.
    Ke XX; Zhang D; Zhu S; Xia Q; Xiang Z; Cui H
    PLoS One; 2014; 9(9):e106962. PubMed ID: 25198515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLP overexpression is associated with poor prognosis in Chronic Lymphocytic Leukemia and its inhibition induces leukemic cell death.
    Alves-Silva JC; de Carvalho JL; Rabello DA; Serejo TRT; Rego EM; Neves FAR; Lucena-Araujo AR; Pittella-Silva F; Saldanha-Araujo F
    Invest New Drugs; 2018 Oct; 36(5):955-960. PubMed ID: 29855824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Histone Methyltransferase G9a Promotes Cholangiocarcinogenesis Through Regulation of the Hippo Pathway Kinase LATS2 and YAP Signaling Pathway.
    Ma W; Han C; Zhang J; Song K; Chen W; Kwon H; Wu T
    Hepatology; 2020 Oct; 72(4):1283-1297. PubMed ID: 31990985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G9a drives hypoxia-mediated gene repression for breast cancer cell survival and tumorigenesis.
    Casciello F; Al-Ejeh F; Kelly G; Brennan DJ; Ngiow SF; Young A; Stoll T; Windloch K; Hill MM; Smyth MJ; Gannon F; Lee JS
    Proc Natl Acad Sci U S A; 2017 Jul; 114(27):7077-7082. PubMed ID: 28630300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined Targeting of G9a and Checkpoint Kinase 1 Synergistically Inhibits Pancreatic Cancer Cell Growth by Replication Fork Collapse.
    Urrutia G; Salmonson A; Toro-Zapata J; de Assuncao TM; Mathison A; Dusetti N; Iovanna J; Urrutia R; Lomberk G
    Mol Cancer Res; 2020 Mar; 18(3):448-462. PubMed ID: 31822519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation.
    Zhang J; He P; Xi Y; Geng M; Chen Y; Ding J
    Oncotarget; 2015 Feb; 6(5):2917-27. PubMed ID: 25595900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SPOP mutation induces DNA methylation via stabilizing GLP/G9a.
    Zhang J; Gao K; Xie H; Wang D; Zhang P; Wei T; Yan Y; Pan Y; Ye W; Chen H; Shi Q; Li Y; Zhao SM; Hou X; Weroha SJ; Wang Y; Zhang J; Karnes RJ; He HH; Wang L; Wang C; Huang H
    Nat Commun; 2021 Sep; 12(1):5716. PubMed ID: 34588438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.